Microencapsulation of Dye‐ and Drug‐Loaded Particles for Imaging and Controlled Release of Multiple Drugs

A polymeric microcapsule that can house different drug-loaded particles using a simple emulsion packaging technique is presented. Compared to the neat microparticles, microcapsules simultaneously release multiple drugs in a sustained manner. These microcapsules could provide a means of controlling release of multiple drugs.

[1]  N. Peppas,et al.  A novel model and experimental analysis of hydrophilic and hydrophobic agent release from biodegradable polymers. , 2009, Journal of biomedical materials research. Part A.

[2]  R. Löbenberg,et al.  Targeted delivery of nanoparticles for the treatment of lung diseases. , 2008, Advanced drug delivery reviews.

[3]  David S. Jones,et al.  Analysis of in vitro drug dissolution from PCL melt extrusion , 2010 .

[4]  H. Yoo.  Preparation of biodegradable polymeric hollow microspheres using O/O/W emulsion stabilized by Labrafil. , 2006, Colloids and surfaces. B, Biointerfaces.

[5]  Craig W Lindsley,et al.  Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. , 2009, Trends in pharmacological sciences.

[6]  C. Remuñán-López,et al.  Microencapsulated chitosan nanoparticles for lung protein delivery. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[7]  L J Lesko,et al.  Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling , 2007, Clinical pharmacology and therapeutics.

[8]  B. Escuder,et al.  Supramolecular hydrogels for enzymatically triggered self-immolative drug delivery , 2010 .

[9]  R. Misra,et al.  New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: synthesis, characterization and in vitro drug delivery response. , 2010, Acta biomaterialia.

[10]  J. Siepmann,et al.  How porosity and size affect the drug release mechanisms from PLGA-based microparticles. , 2006, International journal of pharmaceutics.

[11]  F. Forni,et al.  Surface drug removal from ibuprofen-loaded PLA microspheres. , 2000, International journal of pharmaceutics.

[12]  S. C. Loo,et al.  Formation and degradation of biodegradable triple-layered microparticles. , 2010, Macromolecular rapid communications.

[13]  K. Bouchemal,et al.  Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[14]  E. C. Tan,et al.  Fabrication of double-walled microspheres for the sustained release of doxorubicin. , 2005, Journal of colloid and interface science.

[15]  J. Siepmann,et al.  PLGA-based drug delivery systems: importance of the type of drug and device geometry. , 2008, International journal of pharmaceutics.

[16]  Say Chye Joachim Loo,et al.  Altering the drug release profiles of double-layered ternary-phase microparticles. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Say Chye Joachim Loo,et al.  One-step fabrication of triple-layered polymeric microparticles with layer localization of drugs as a novel drug-delivery system. , 2010, Small.

[18]  S. Zustiak,et al.  Characterization of protein release from hydrolytically degradable poly(ethylene glycol) hydrogels , 2011, Biotechnology and bioengineering.

[19]  Say Chye Joachim Loo,et al.  Manipulation of process parameters to achieve different ternary phase microparticle configurations. , 2010, Acta biomaterialia.

[20]  R. Aster,et al.  Drug‐induced immune thrombocytopenia: pathogenesis, diagnosis, and management , 2009, Journal of thrombosis and haemostasis : JTH.

[21]  N. Peppas,et al.  Modeling of drug release from biodegradable polymer blends. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  A. Telenti,et al.  Efavirenz Plasma Levels Can Predict Treatment Failure and Central Nervous System Side Effects in Hiv-1-infected Patients , 2022 .

[23]  K. Johnston,et al.  Uniform encapsulation of stable protein nanoparticles produced by spray freezing for the reduction of burst release. , 2005, Journal of pharmaceutical sciences.

[24]  Sam N. Rothstein,et al.  A “tool box” for rational design of degradable controlled release formulations , 2011 .

[25]  Erin B. Lavik,et al.  Using Polymer Chemistry to Modulate the Delivery of Neurotrophic Factors from Degradable Microspheres: Delivery of BDNF , 2009, Pharmaceutical Research.

[26]  N. Pannu,et al.  An overview of drug-induced acute kidney injury , 2008, Critical care medicine.

[27]  S. B. Tiwari,et al.  Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Andreas Greiner,et al.  Novel 'nano in nano' composites for sustained drug delivery: biodegradable nanoparticles encapsulated into nanofiber non-wovens. , 2010, Macromolecular bioscience.

[29]  J. Siepmann,et al.  Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio. , 2010, International journal of pharmaceutics.

[30]  T. Mandal,et al.  Poly(d,l-Lactide-Co-Glycolide) Encapsulated Poly(Vinyl Alcohol) Hydrogel as a Drug Delivery System , 2002, Pharmaceutical Research.

[31]  Y. Kawashima,et al.  In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  C. Guillemette,et al.  Glucuronidation of the Antiretroviral Drug Efavirenz by UGT2B7 and an in Vitro Investigation of Drug-Drug Interaction with Zidovudine , 2009, Drug Metabolism and Disposition.

[33]  R. Yoshimura,et al.  Fluctuating plasma levels of the active moiety of risperidone is related to occurrence of extrapyramidal symptoms , 2009, International journal of psychiatry in clinical practice.

[34]  R. Tan,et al.  Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids. , 2007, International journal of pharmaceutics.

[35]  G. Stack,et al.  Drug-induced thrombocytopenia. , 2009, Archives of pathology & laboratory medicine.